Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Genetic toxicity: in vitro

Currently viewing:

Administrative data

Endpoint:
in vitro gene mutation study in bacteria
Type of information:
experimental study
Adequacy of study:
key study
Study period:
08 August 2019 to 20 August 2019
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2019
Report date:
2019

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
OECD Guideline 471 (Bacterial Reverse Mutation Assay)
Qualifier:
according to guideline
Guideline:
EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
Qualifier:
according to guideline
Guideline:
EPA OPPTS 870.5100 - Bacterial Reverse Mutation Test (August 1998)
Qualifier:
according to guideline
Guideline:
other: Japanese Ministry of Economy, Trade and Industry, Japanese Ministry of Health, Labor and Welfare and Japanese Ministry of Agriculture, Forestry and Fisheries, 24 November 2000
Qualifier:
according to guideline
Guideline:
other: ICH S2(R1) guideline adopted June 2012 (ICH S2(R1) Federal Register. Adopted 2012; 77:33748-33749)
GLP compliance:
yes (incl. QA statement)
Type of assay:
bacterial reverse mutation assay

Test material

Constituent 1
Chemical structure
Reference substance name:
Reaction mass of 1-methyl-4-(propan-2-ylidene)cyclohexyl acetate and 2-(4-methylcyclohex-3-en-1-yl)propan-2-yl acetate
EC Number:
904-693-9
Molecular formula:
C12H20O2
IUPAC Name:
Reaction mass of 1-methyl-4-(propan-2-ylidene)cyclohexyl acetate and 2-(4-methylcyclohex-3-en-1-yl)propan-2-yl acetate
Test material form:
liquid

Method

Species / strainopen allclose all
Species / strain / cell type:
S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
Species / strain / cell type:
E. coli WP2 uvr A
Metabolic activation:
with and without
Metabolic activation system:
Type and composition of metabolic activation system:
- Source of S9: Moltox
- Inducing agent: Phenobarbital-5,6 and Benzoflavone
- Method of preparation of S9 mix: Matsushima et al., In vitro metabolic activation in mutagenesis testing (F.J. de Serres, ed.), Elsevier, 1976, p85
- Quality controls of S9: enzymatic activity, sterility, and metabolic capability
Test concentrations with justification for top dose:
Experiment 1: 1.5, 5, 15, 50, 150, 500, 1500 and 5000 μg/plate
Experiment 2: 0.5, 1.5, 5, 15, 50, 150, 500, 1500 μg/plate (All Salmonella strains)
Experiment 2: 1.5, 5, 15, 50, 150, 500, 1500, 5000 (E.coli strain WP2uvrA)
Vehicle / solvent:
- Vehicle(s)/solvent(s) used: DMSO
- Justification for choice of solvent/vehicle: The test item was immiscible in sterile distilled water at 50 mg/mL but was fully miscible in dimethyl sulphoxide at the same concentration in solubility checks performed in-house. Dimethyl sulphoxide was therefore selected as the vehicle.
Controls
Untreated negative controls:
yes
Negative solvent / vehicle controls:
yes
True negative controls:
no
Positive controls:
yes
Positive control substance:
4-nitroquinoline-N-oxide
9-aminoacridine
N-ethyl-N-nitro-N-nitrosoguanidine
benzo(a)pyrene
other: 2-Aminoanthracene
Details on test system and experimental conditions:
METHOD OF APPLICATION:
- Experiment 1: in agar (plate incorporation)
- Experiment 2: preincubation

DURATION
- Preincubation period: 20 minutes (Experiment 2)
- Exposure duration: 48-72 hours

NUMBER OF REPLICATIONS: 3

DETERMINATION OF CYTOTOXICITY
- Method: The plates were viewed microscopically for evidence of thinning
Evaluation criteria:
There are several criteria for determining a positive result. Any, one, or all of the following can be used to determine the overall result of the study:
1. A dose-related increase in mutant frequency over the dose range tested (De Serres and Shelby, 1979).
2. A reproducible increase at one or more concentrations.
3. Biological relevance against in-house historical control ranges.
4. A fold increase greater than two times the concurrent solvent control for TA100, TA98 and WP2uvrA or a three-fold increase for TA1535 and TA1537 (especially if accompanied by an out-of-historical range response (Cariello and Piegorsch, 1996)).
5. Statistical analysis of data as determined by UKEMS (Mahon et al., 1989).
A test item will be considered non-mutagenic (negative) in the test system if the above criteria are not met. Although most experiments will give clear positive or negative results, in some instances the data generated will prohibit making a definite judgment about test item activity. Results of this type will be reported as equivocal.
Statistics:
Statistical significance was confirmed by using Dunnett’s Regression Analysis (p < 0.05) for those values that indicate statistically significant increases in the frequency of revertant colonies compared to the concurrent solvent control.

Results and discussion

Test results
Key result
Species / strain:
bacteria, other: S. typhimurium TA 1535, TA 1537, TA 98 and TA 100 and E. coli WP2 uvr A
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Additional information on results:
Controls:
- Prior to use, the master strains were checked for characteristics, viability and spontaneous reversion rate (all were found to be satisfactory). The amino acid supplemented top agar and the S9-mix used in both experiments was shown to be sterile. The test item formulation was also shown to be sterile. These data are not given in the report.
- Results for the negative controls (spontaneous mutation rates) are considered to be acceptable.
- The vehicle (dimethyl sulphoxide) control plates gave counts of revertant colonies within the normal range. All of the positive control chemicals used in the test induced marked increases in the frequency of revertant colonies, both with and without metabolic activation. Thus, the sensitivity of the assay and the efficacy of the S9-mix were validated.

Experiment 1:
- Test item treatment caused a visible reduction in the growth of the bacterial background lawns of all of the tester strains dosed in both the absence and presence of metabolic activation. Weakened bacterial background lawns were noted in the absence of metabolic activation from 500 μg/plate to all of the Salmonella strains and at 5000 μg/plate to WP2uvrA. In the presence of metabolic activation, weakened bacterial background lawns were noted to all of the tester strains from 500 μg/plate to TA100, TA1535 and TA1537, 1500 μg/plate to TA98 and at 5000 μg/plate to WP2uvrA.
- No test item precipitate was observed on the plates at any of the doses tested in either the presence or absence of metabolic activation (S9-mix).
- There were no biologically relevant increases in the frequency of revertant colonies recorded for any of the bacterial strains, with any dose of the test item, either with or without metabolic activation (S9-mix). One statistically significant value was noted (TA98 at 50 μg/plate in the presence of metabolic activation (S9-mix)), This value was not identified as statistically significant, as this response was within the in-house historical vehicle/untreated control range for the strain and was, therefore considered of no biological relevance.

Experiment 2:
- Test item treatment caused a visible reduction in the growth of the bacterial background lawns of all of the tester strains dosed in both the absence and presence of metabolic activation. Weakened bacterial background lawns were noted in the absence of metabolic activation from 50 μg/plate to TA100 and 150 μg/plate to TA1537, TA1535, TA98 and WP2uvrA. In the presence of metabolic activation, weakened bacterial background lawns were noted to all of the tester strains from 150 μg/plate to TA100, 500 μg/plate to TA1535, TA98 and TA1537 and from 1500 μg/plate to WP2uvrA.
- No test item precipitate was observed on the plates at any of the doses tested in either the presence or absence of metabolic activation (S9-mix).
- There were no significant increases in the frequency of revertant colonies recorded for any of the bacterial strains, with any dose of the test item, either with or without metabolic activation (S9-mix).

Applicant's summary and conclusion

Conclusions:
The test material was considered non-mutagenic under the conditions of this test.
Executive summary:

The test substance was evaluated in a bacterial reverse mutation assay performed according to OECD 471 and following GLP using Salmonella typhimurium strains TA98, TA100, TA 1535 and TA1537 and Escherichia coli strain WP2 uvrA both in the presence and absence of an exogenous metabolic activation system (S9-mix). The test substance was evaluated using an initial plate incorporation assay and a confirmatory preincubation procedure in triplicate with and without metabolic activation. In the first experiment, test substance concentrations of 1.5, 5, 15, 50, 150, 500, 1500 and 5000 µg/plate were assessed. In the second experiment, test substance concentrations of 0.5, 1.5, 5, 15, 50, 150, 500, 1500 μg/plate (All Salmonella strains), and 1.5, 5, 15, 50, 150, 500, 1500, 5000 μg/plate (WP2uvrA) were assessed. The vehicle (dimethyl sulphoxide) control plates gave counts of revertant colonies within the normal range. All of the positive control chemicals used in the test induced marked increases in the frequency of revertant colonies, both with and without metabolic activation. Thus, the sensitivity of the assay and the efficacy of the S9-mix were validated. In the first mutation test, the test item induced a visible reduction in the growth of the bacterial background lawns of all of the tester strains dosed in the absence and presence of metabolic activation, initially from 500 μg/plate. In the second experiment, the test item induced a visible reduction in the growth of the bacterial background lawns of all of the tester strains dosed in the absence of metabolic activation, initially from 50 μg/plate. In the presence of metabolic activation, the lowest test item concentration at which toxicity was initially observed was strain dependant and started from 150 μg/plate. No test item precipitate was observed on any of the plates. There were no biologically relevant increases in the frequency of revertant colonies recorded for any of the bacterial strains, with any dose of the test item, either with or without metabolic activation (S9-mix) in Experiment 1. One statistically significant value was noted (TA98 at 50 μg/plate in the presence of metabolic activation (S9-mix)). This value was within the in-house historical vehicle/untreated control range for the strain and was, therefore considered of no biological relevance. Similarly, no significant increases in the frequency of revertant colonies were recorded for any of the bacterial strains, with any dose of the test item, either with or without metabolic activation (S9-mix) in Experiment 2. Therefore, the test material was considered to be non-mutagenic under the conditions of this test.